Keppra · DIN 02247027 · 250 mg · tablet
Limited Use, Reason for Use code 473 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 473 required
Write on scriptReason for Use code 473 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 473
Reason for Use code 473
As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Keppra · DIN 02247027
Manufacturer: UCB Canada Inc.; listing date 2007-11-10
Health Canada: Marketed since 2010-09-10 · brand KEPPRA · ATC N03AX14 LEVETIRACETAM · form Tablet · route Oral · ingredients LEVETIRACETAM 250 MG · company Ucb canada inc · schedule Prescription
Ministry pays: $0.3210 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02247027)
Source record
DIN 02247027: Keppra
Raw flags: sec12=Y, sec3=Y
Item: 281200091; group id 434; item number 1083; lccId 00266; manufacturer id UCB
Source form: Tab; strength: 250mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $1.7836; ministry $0.3210
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02247027
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71262
Interchangeable products
Ach-Levetiracetam · DIN 02399776 · $0.3210
Act Levetiracetam · DIN 02274183 · $0.3210
Apo-Levetiracetam · DIN 02285924 · $0.3210
Auro-Levetiracetam · DIN 02375249 · $0.3210
Jamp Levetiracetam Tablets · DIN 02504553 · $0.3210
Jamp-Levetiracetam · DIN 02403005 · $0.3210
Levetiracetam · DIN 02353342 · $0.3210
Levetiracetam · DIN 02442531 · $0.3210
M-Levetiracetam · DIN 02524562 · $0.3210
Mint-Levetiracetam · DIN 02442388 · $0.3210
NRA-Levetiracetam · DIN 02499193 · $0.3210
PMS-Levetiracetam · DIN 02296101 · $0.3210
Riva-Levetiracetam · DIN 02482274 · $0.3210
Sandoz Levetiracetam · DIN 02461986 · $0.3210
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02247027
Shortage record checked October 6, 2026